Key Takeaways From J&J's Big Quarter

In this video, David Williamson reviews Johnson & Johnson's latest earnings report. The over-the-counter and nutritional business both grew, as did the pharma division, with a blood thinner holding its own and a new diabetes drug that looks promising. Medical devices saw a 10% uptick, but that was considered a disappointment in light of recent acquisitions.

David says he's neutral on the stock, but he also notes its 2.9% dividend and thinks it could prove to be a safe long-term investment. Check out the video for more details.

Is bigger really better?
Involved in everything from baby powder to biotech, Johnson & Johnson has its critics convinced that the company is spread way too thin. If you want to know whether J&J is nothing but a bloated corporate whale -- or a well-diversified giant that's perfect for your portfolio -- check out the Fool's new premium report outlining the Johnson & Johnson story in terms that any investor can understand. Claim your copy by clicking here now


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2366812, ~/Articles/ArticleHandler.aspx, 10/23/2014 6:03:38 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement